Cargando…
MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study
BACKGROUND: A substantial impediment to progress in trials of new therapies in neuromuscular disorders is the absence of responsive outcome measures that correlate with patient functional deficits and are sensitive to early disease processes. Irrespective of the primary molecular defect, neuromuscul...
Autores principales: | Morrow, Jasper M, Sinclair, Christopher D J, Fischmann, Arne, Machado, Pedro M, Reilly, Mary M, Yousry, Tarek A, Thornton, John S, Hanna, Michael G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Pub. Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672173/ https://www.ncbi.nlm.nih.gov/pubmed/26549782 http://dx.doi.org/10.1016/S1474-4422(15)00242-2 |
Ejemplares similares
-
Reproducibility, and age, body-weight and gender dependency of candidate skeletal muscle MRI outcome measures in healthy volunteers
por: Morrow, Jasper M., et al.
Publicado: (2014) -
Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias()
por: Morrow, Jasper M., et al.
Publicado: (2013) -
Evidence of nerve hypertrophy in patients with inclusion body myositis on lower limb MRI
por: Elmansy, Mostafa, et al.
Publicado: (2022) -
Validation of MRC Centre MRI calf muscle fat fraction protocol as an outcome measure in CMT1A
por: Morrow, Jasper M., et al.
Publicado: (2018) -
Extra-ocular muscle MRI in genetically-defined mitochondrial disease
por: Pitceathly, Robert D. S., et al.
Publicado: (2015)